CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Ionis Begins Dosing in Phase I/II Dravet Syndrome Study

Phase 1Positive
AI Analysis

Summary

Ionis Pharmaceuticals has initiated dosing in a Phase I/II clinical trial for a Dravet Syndrome treatment. This represents early-stage development progress for the condition.

Clinical Trial Data

Phase

Phase I/II

Importance:5/10
Sentiment:
0.50
Dravet SyndromePhase I/IIClinical TrialIonis
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 2:04 PM

Read Original